Fibrinogen Concentrates Market: By Disease Indication (Afibrinogenemia, Dysfibrinogenemia, and Hypofibrinogenemia, Acquired Hypofibrinogenemia, Bleeding Treatment), By Distribution Channel (Hospitals, Ambulatory Surgical Centers, Others) and Geography

Purchase Option

$ 4400
$ 6600
$ 8900

Fibrinogen Concentrates Market size was valued at USD 2,864 million in 2023 and is poised to grow at a significant CAGR of 5.11% from 2024-2030. Due to the increase in the number of cases of bleeding disorders such as congenital afibrinogenemia, hypofibrinogenemia dysfibrinogenemia, low levels of fibrinogen could lead to thrombosis, blood clot formation, and other disorders. Fibrinogen Increasing the R&D activities in biotechnology, increasing awareness, increasing medical infrastructure, and rising government emphasis on the healthcare sector will fuel the market growth. However, the high cost of fibrinogen concentrates test, lack of skilled medical professionals and the concerns related to adverse effects such as nausea, vomiting, chills, dyspnea, and arterial thrombosis are the major factors that hinder the growth of the fibrinogen concentrates market.

Fibrinogen Concentrates Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

5.11%

Largest Market

North-America

Fastest Growing Market

Asia Pacific
Fibrinogen Concentrates Market Dynamics

In the recent years, Due to changing in the life styles and increased in the stress levels which leads to increase the number of many blood related disorders such as congenital afibrinogenemia, hypofibrogenemia, dysfibrinogenemia and others. Mainly, fibrinogen concentrates are utilized for the preparation of anti coagulates which is used to treat the above disorders. In addition, increasing expenditure on healthcare, growing awareness regarding the fibrinogen concentrates and rising biologic therapy, increasing drug development and Food and Drug Administration (FDA) approvals are estimated to boost market growth in near future.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Fibrinogen Concentrates Market Segmentation

By Disease Indication
  • Afibrinogenemia, Dysfibrinogenemia, and Hypofibrinogenemia
  • Acquired Hypofibrinogenemia
  • Bleeding Treatment
By Distribution Channel
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
By Geography
  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa (MEA)

Frequently Asked Questions

The fibrinogen concentrates market size was valued at USD 2,864 million in 2023

Hualan Biological Engineering, Jiangxi Boya Bio-Pharmaceutical, LFB Group, ProFibrix BV, Shanghai RAAS

North America is dominating the fibrinogen concentrates market

1. Executive Summary
2.  Global Fibrinogen Concentrates Market Introduction 
2.1. Global Fibrinogen Concentrates Market  - Taxonomy
2.2. Global Fibrinogen Concentrates Market  - Definitions
2.2.1. Disease Indication
2.2.2. Distribution Channel
2.2.3. Region
3. Global Fibrinogen Concentrates Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Key Developments
4. Global Fibrinogen Concentrates Market  By Disease Indication, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
4.1. Afibrinogenemia, Dysfibrinogenemia, and Hypofibrinogenemia
4.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
4.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
4.1.3. Market Opportunity Analysis 
4.2. Acquired Hypofibrinogenemia
4.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
4.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
4.2.3. Market Opportunity Analysis 
4.3. Bleeding Treatment
4.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
4.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
4.3.3. Market Opportunity Analysis 
5. Global Fibrinogen Concentrates Market  By Distribution Channel, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
5.1. Hospitals
5 1 1  Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Ambulatory Surgical Centers
5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Others
5.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6.  Global Fibrinogen Concentrates Market  By Region, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
6.1. North America
6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Europe
6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Asia Pacific
6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Latin America
6.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. MEA
6.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
6.6.  Global Fibrinogen Concentrates Market - Opportunity Analysis Index, By Distribution Channel, Disease Indication, and Region, 2024-2030
7. North America Fibrinogen Concentrates Market, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
7.1. Disease Indication Analysis,  2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
7.1.1. Afibrinogenemia, Dysfibrinogenemia, and Hypofibrinogenemia
7.1.2. Acquired Hypofibrinogenemia
7.1.3. Bleeding Treatment
7.2. Distribution Channel Analysis,  2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
7.2.1. Hospitals
7.2.2. Ambulatory Surgical Centers
7.2.3. Others
7.3. Country Analysis,  2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
7.3.1. USA
7.3.2. Canada
8. Europe Fibrinogen Concentrates Market, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
8.1. Disease Indication Analysis,  2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.1.1. Afibrinogenemia, Dysfibrinogenemia, and Hypofibrinogenemia
8.1.2. Acquired Hypofibrinogenemia
8.1.3. Bleeding Treatment
8.2. Distribution Channel Analysis,  2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.2.1. Hospitals
8.2.2. Ambulatory Surgical Centers
8.2.3. Others
8.3. Country Analysis,  2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.3.1. Germany
8.3.2. UK
8.3.3. France
8.3.4. Italy
8.3.5. Spain
8.3.6. Rest of Europe
9. Asia Pacific Fibrinogen Concentrates Market, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
9.1. Disease Indication Analysis,  2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1. Afibrinogenemia, Dysfibrinogenemia, and Hypofibrinogenemia
9.1.2. Acquired Hypofibrinogenemia
9.1.3. Bleeding Treatment
9.2. Distribution Channel Analysis,  2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1. Hospitals
9.2.2. Ambulatory Surgical Centers
9.2.3. Others
9.3. Country Analysis,  2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1. China 
9.3.2. India
9.3.3. Japan
9.3.4. South Korea
9.3.5. ASEAN Countries
9.3.6. Rest of APAC
10. Latin America Fibrinogen Concentrates Market, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
10.1. Disease Indication Analysis,  2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1. Afibrinogenemia, Dysfibrinogenemia, and Hypofibrinogenemia
10.1.2. Acquired Hypofibrinogenemia
10.1.3. Bleeding Treatment
10.2. Distribution Channel Analysis,  2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1. Hospitals
10.2.2. Ambulatory Surgical Centers
10.2.3. Others
10.3. Country Analysis,  2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1. Brazil
10.3.2. Mexico
10.3.3. Argentina
10.3.4. Rest of Latin America
11. MEA Fibrinogen Concentrates Market, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
11.1. Disease Indication Analysis,  2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1. Afibrinogenemia, Dysfibrinogenemia, and Hypofibrinogenemia
11.1.2. Acquired Hypofibrinogenemia
11.1.3. Bleeding Treatment
11.2. Distribution Channel Analysis,  2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1. Hospitals
11.2.2. Ambulatory Surgical Centers
11.2.3. Others
11.3. Country Analysis,  2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1. GCC Countries
11.3.2. Israel
11.3.3. South Africa
11.3.4. Rest of MEA
12.  Competition Landscape
12.1. Strategic Dashboard of Top Market Players
12.2. Company Profiles (Introduction, Financial Analysis, By Product Offerings, Key Developments, Strategies, and SWOT Analysis)
12.2.1. CSL Behring 
12.2.2. Baxter International Inc
12.2.3. GC Biopharma corp
12.2.4. LFB Group
12.2.5. Shanghai RAAS
12.2.6. Octapharma AG
12.2.7. Novartis AG
12.2.8. Harbin Pacific Biopharmaceutical Co. Ltd
12.2.9. Biotest AG
12.2.10. Japan Blood Products Organization
13.  Research Methodology
14.  Key Assumptions and Acronyms
  • CSL Behring
  • Baxter International Inc
  • GC Biopharma corp
  • LFB Group
  • Shanghai RAAS
  • Octapharma AG
  • Novartis AG
  • Harbin Pacific Biopharmaceutical Co. Ltd
  • Biotest AG
  • Japan Blood Products Organization

Adjacent Markets